Cargando…
Targeting the Wnt/β-Catenin Signaling Pathway in Liver Cancer Stem Cells and Hepatocellular Carcinoma Cell Lines with FH535
Activation of the Wnt/β-catenin pathway has been observed in at least 1/3 of hepatocellular carcinomas (HCC), and a significant number of these have mutations in the β-catenin gene. Therefore, effective inhibition of this pathway could provide a novel method to treat HCC. The purposed of this study...
Autores principales: | Gedaly, Roberto, Galuppo, Roberto, Daily, Michael F., Shah, Malay, Maynard, Erin, Chen, Changguo, Zhang, Xiping, Esser, Karyn A., Cohen, Donald A., Evers, B. Mark, Jiang, Jieyun, Spear, Brett T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062395/ https://www.ncbi.nlm.nih.gov/pubmed/24940873 http://dx.doi.org/10.1371/journal.pone.0099272 |
Ejemplares similares
-
FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway
por: Chen, Yanyan, et al.
Publicado: (2017) -
FH535 Inhibited Migration and Growth of Breast Cancer Cells
por: Iida, Joji, et al.
Publicado: (2012) -
FH535 inhibited metastasis and growth of pancreatic cancer cells
por: Wu, Meng-Yao, et al.
Publicado: (2015) -
FH535 Suppresses Osteosarcoma Growth In Vitro and Inhibits Wnt Signaling through Tankyrases
por: Gustafson, Carl T., et al.
Publicado: (2017) -
Autophagic flux modulation by Wnt/β-catenin pathway inhibition in hepatocellular carcinoma
por: Turcios, Lilia, et al.
Publicado: (2019)